166 related articles for article (PubMed ID: 3767545)
1. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine.
Svenson K; Bohman SO; Hällgren R
Arch Intern Med; 1986 Oct; 146(10):2007-10. PubMed ID: 3767545
[TBL] [Abstract][Full Text] [Related]
2. Renal histopathologic alterations in patients treated with cyclosporine for uveitis.
Palestine AG; Austin HA; Balow JE; Antonovych TT; Sabnis SG; Preuss HG; Nussenblatt RB
N Engl J Med; 1986 May; 314(20):1293-8. PubMed ID: 3702930
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for cyclosporine-induced nephropathy in patients with autoimmune diseases. International Kidney Biopsy Registry of Cyclosporine in Autoimmune Diseases.
Feutren G; Mihatsch MJ
N Engl J Med; 1992 Jun; 326(25):1654-60. PubMed ID: 1588978
[TBL] [Abstract][Full Text] [Related]
4. Focal glomerulosclerosis and nephron atrophy in rats on long-term cyclosporine treatment.
Bäckman L; Sundelin B; Bohman SO
APMIS Suppl; 1988; 4():27-36. PubMed ID: 3224023
[TBL] [Abstract][Full Text] [Related]
5. Clinical and morphological prognostic factors in membranous nephropathy: significance of focal segmental glomerulosclerosis.
Dumoulin A; Hill GS; Montseny JJ; Meyrier A
Am J Kidney Dis; 2003 Jan; 41(1):38-48. PubMed ID: 12500220
[TBL] [Abstract][Full Text] [Related]
6. Morphology of cyclosporine nephrotoxicity in human heart transplant recipients.
Chomette G; Auriol M; Beaufils H; Rottemburg J; Cabrol C
J Heart Transplant; 1986; 5(4):273-8. PubMed ID: 3305818
[TBL] [Abstract][Full Text] [Related]
7. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A; El-Basuony F; Mahmoud I; Sheashaa H; Sabry A; Hassan R; Taha N; Hassan N; Sayed-Ahmad N; Sobh M
Nephrol Dial Transplant; 2005 Nov; 20(11):2433-8. PubMed ID: 16204303
[TBL] [Abstract][Full Text] [Related]
8. [Renal lesions induced by cyclosporin. Apropos of 4 renal biopsies and 22 necropsies of recipients of heart transplant].
Chomette G; Auriol M; Beaufils H; Rottembourg A; Cabrol C
Ann Pathol; 1986; 6(1):29-36. PubMed ID: 3521626
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants.
Nizze H; Mihatsch MJ; Zollinger HU; Brocheriou C; Gokel JM; Henry K; Sloane JP; Stovin PG
Clin Nephrol; 1988 Nov; 30(5):248-60. PubMed ID: 3063420
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine: from renal transplantation to autoimmune diseases.
Ponticelli C
Ann N Y Acad Sci; 2005 Jun; 1051():551-8. PubMed ID: 16126995
[TBL] [Abstract][Full Text] [Related]
11. [Cyclosporin in autoimmune diseases].
Frey FJ
Schweiz Med Wochenschr; 1990 May; 120(21):772-86. PubMed ID: 2190313
[TBL] [Abstract][Full Text] [Related]
12. Longterm low dose cyclosporine in patients with rheumatoid arthritis: renal function loss without structural nephropathy.
Landewé RB; Dijkmans BA; van der Woude FJ; Breedveld FC; Mihatsch MJ; Bruijn JA
J Rheumatol; 1996 Jan; 23(1):61-4. PubMed ID: 8838509
[TBL] [Abstract][Full Text] [Related]
13. Renal morphology after cyclosporin A therapy in rheumatoid arthritis patients. International Kidney Biopsy Registry of Cyclosporin (Sandimmun) in Autoimmune Diseases.
Br J Rheumatol; 1993 Mar; 32 Suppl 1():65-71. PubMed ID: 8448642
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of chronic renal disease in heart transplant recipients: importance of pretransplantation native kidney histologic evaluation.
Lewis RM; Verani RR; Vo C; Katz SM; Van Buren CT; Radovancevic B; Kerman RH; Frazier OH; Kahan BD
J Heart Lung Transplant; 1994; 13(3):376-80. PubMed ID: 8061012
[TBL] [Abstract][Full Text] [Related]
15. Cyclosporine-associated chronic nephropathy.
Myers BD; Ross J; Newton L; Luetscher J; Perlroth M
N Engl J Med; 1984 Sep; 311(11):699-705. PubMed ID: 6382005
[TBL] [Abstract][Full Text] [Related]
16. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months.
Bignardi L; Neild GH; Hartley RB; Taube DH; Cameron JS; Rudge CJ; Williams DG; Ogg CS
Nephrol Dial Transplant; 1987; 2(5):366-70. PubMed ID: 3122115
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporin A nephropathy: standardization of the evaluation of kidney biopsies.
Mihatsch MJ; Antonovych T; Bohman SO; Habib R; Helmchen U; Noel LH; Olsen S; Sibley RK; Kemény E; Feutren G
Clin Nephrol; 1994 Jan; 41(1):23-32. PubMed ID: 8137566
[TBL] [Abstract][Full Text] [Related]
19. Hemolytic uremic syndrome in patients with Behçet's disease treated with cyclosporin A: report of 2 cases.
Beaufils H; de Groc F; Gubler MC; Wechsler B; Le Hoang P; Baumelou A; Chomette G; Jacobs C
Clin Nephrol; 1990 Oct; 34(4):157-62. PubMed ID: 2257701
[TBL] [Abstract][Full Text] [Related]
20. Kidney function in cyclosporine-treated pediatric heart transplant recipients.
Laine J; Jalanko H; Leijala M; Sairanen H; Holmberg C
J Heart Lung Transplant; 1997 Dec; 16(12):1217-24. PubMed ID: 9436133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
